Whitehawk Therapeutics presents ADC preclinical data at AACR 2026

Kura Oncology reports early activity for darlifarnib–cabozantinib combination in cabozantinib‑pretreated ccRCC

Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic

Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent

Philips secures FDA clearance for Spectral CT Verida system

Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology

Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential

Asgard Therapeutics appoints chief medical officer

Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

Senhwa Biosciences secures up to TWD500m funding for AI-driven drug development

CrossBridge Bio to be acquired by Eli Lilly

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

Kazia Therapeutics in-licenses SETDB1 inhibitor drug development platform

Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO

Genmab reports positive safety data for Rina-S combination in ovarian cancer